NCT02756247 2022-10-10A Clinical Trial of Buparlisib and Ibrutinib in LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed37 enrolled
NCT01719250 2018-10-09Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase EARLY_PHASE1 Completed7 enrolled
NCT01693614 2018-09-28Safety and Efficacy of BKM120 in Relapsed and Refractory NHLNovartisPhase 2 Completed72 enrolled 15 charts